Literature DB >> 7759209

Two cases of urogenital malignancies in male patients undergoing maintenance haemodialysis.

Y Makita1, T Iwamoto, K Sagiyama, A Nagaoka, M Kinjo, M Noguchi, K Aramaki, S Okuda, M Fujishima.   

Abstract

We report two cases of urogenital malignancies, prostatic cancer in a 72-year-old man and urinary bladder carcinoma in a 50-year-old man, that developed during maintenance haemodialysis. The former patient responded to hormonal therapy with diethylstilboestrol and is still alive on maintenance haemodialysis, but the latter patient did not respond to treatment, being past cure in the far advanced stage. There are few clinical symptoms suggesting the existence of urogenital malignancies in dialysis patients and screening methods such as urine cytology or roentgenology must be restricted because of extremely reduced urine volume. However, the high incidence of urogenital malignancies in such patients is well recognized. Screening examinations with ultrasonography and/or CT scan following digital rectal examination or testing for serum prostate-specific antigen should be performed at least every 6 months.

Entities:  

Mesh:

Year:  1994        PMID: 7759209     DOI: 10.1007/BF02767729

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

Review 1.  The diagnosis and treatment of prostate cancer.

Authors:  G L Andriole; W J Catalona
Journal:  Annu Rev Med       Date:  1991       Impact factor: 13.739

2.  Prostatic cancer in a patient on long-term hemodialysis.

Authors:  I Sasagawa; K Suzuki; M Ishizaki; Y Shishido; G Futaki; H Takahashi; Y Suzuki; K Nakamura
Journal:  Nephron       Date:  1991       Impact factor: 2.847

3.  Pituitary-gonadal function in chronic renal failure: the effect of luteinizing hormone--releasing hormone and the influence of dialysis.

Authors:  L A Distiller; J E Morley; J Sagel; M Pokroy; R Rabkin
Journal:  Metabolism       Date:  1975-06       Impact factor: 8.694

4.  Acquired renal cystic disease and renal adenocarcinoma in patients on long-term hemodialysis.

Authors:  K D Gardner
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

Review 5.  Host defenses and immunologic alterations associated with chronic hemodialysis.

Authors:  S E Goldblum; W P Reed
Journal:  Ann Intern Med       Date:  1980-10       Impact factor: 25.391

6.  Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients.

Authors:  H Inamoto; R Ozaki; T Matsuzaki; M Wakui; T Saruta; A Osawa
Journal:  Nephron       Date:  1991       Impact factor: 2.847

7.  High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis.

Authors:  A Lindner; V T Farewell; D J Sherrard
Journal:  Nephron       Date:  1981       Impact factor: 2.847

8.  Polyamines: an unrecognised cardiovascular risk factor in chronic dialysis?

Authors:  J D Bagdade; P V Subbaiah; D Bartos; F Bartos; R A Campbell
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

9.  Increased incidence of malignancy during chronic renal failure.

Authors:  A J Matas; R L Simmons; C M Kjellstrand; T J Buselmeier; J S Najarian
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

10.  Metastasizing renal cell carcinoma and acquired renal cystic disease in a hemodialysis patient.

Authors:  A Covarsi; A M Rodriguez; N Marigliano; R Novillo
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.